Abstract
It has long been recognized that generalized deficits in cognitive ability represent a core component of schizophrenia (SCZ), evident before full illness onset and independent of medication. The possibility of genetic overlap between risk for SCZ and cognitive phenotypes has been suggested by the presence of cognitive deficits in first-degree relatives of patients with SCZ; however, until recently, molecular genetic approaches to test this overlap have been lacking. Within the last few years, large-scale genome-wide association studies (GWAS) of SCZ have demonstrated that a substantial proportion of the heritability of the disorder is explained by a polygenic component consisting of many common single-nucleotide polymorphisms (SNPs) of extremely small effect. Similar results have been reported in GWAS of general cognitive ability. The primary aim of the present study is to provide the first molecular genetic test of the classic endophenotype hypothesis, which states that alleles associated with reduced cognitive ability should also serve to increase risk for SCZ. We tested the endophenotype hypothesis by applying polygenic SNP scores derived from a large-scale cognitive GWAS meta-analysis (~5000 individuals from nine nonclinical cohorts comprising the Cognitive Genomics consorTium (COGENT)) to four SCZ case-control cohorts. As predicted, cases had significantly lower cognitive polygenic scores compared to controls. In parallel, polygenic risk scores for SCZ were associated with lower general cognitive ability. In addition, using our large cognitive meta-analytic data set, we identified nominally significant cognitive associations for several SNPs that have previously been robustly associated with SCZ susceptibility. Results provide molecular confirmation of the genetic overlap between SCZ and general cognitive ability, and may provide additional insight into pathophysiology of the disorder.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gottesman II, Gould TD . The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636–645.
Toulopoulou T, Goldberg TE, Mesa IR, Picchioni M, Rijsdijk F, Stahl D et al. Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Arch Gen Psychiatry 2010; 67: 905–913.
Fowler T, Zammit S, Owen MJ, Rasmussen F . A population-based study of shared genetic variation between premorbid IQ and psychosis among male twin pairs and sibling pairs from Sweden. Arch Gen Psychiatry 2012; 69: 460–466.
Almasy L . The role of phenotype in gene discovery in the whole genome sequencing era. Hum Genet 2012; 131: 1533–1540.
Bilder RM, Howe A, Novak N, Sabb FW, Parker DS . The genetics of cognitive impairment in schizophrenia: a phenomic perspective. Trends Cogn Sci 2011; 15: 428–435.
Lee SH, DeCandia TR, Ripke S, Yang J, Sullivan PF, Goddard ME et al. Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), International Schizophrenia Consortium (ISC). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat Genet 2012; 44: 247–250.
Davies G, Tenesa A, Payton A, Yang J, Harris SE, Liewald D et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry 2011; 16: 996–1005.
Plomin R, Haworth CM, Meaburn EL, Price TS, Davis OS . Wellcome Trust Case Control Consortium 2 Common DNA markers can account for more than half of the genetic influence on cognitive abilities. Psychol Sci 2013; 24: 562–568.
Benyamin B, Pourcain B, Davis OS, Davies G, Hansell NK, Brion MJ et al. Childhood intelligence is heritable, highly polygenic and associated with FNBP1L. Mol Psychiatry advance online publication, 29 January 2013; doi:10.1038/mp.2012.184 (e-pub ahead of print).
International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748–752.
McIntosh AM, Gow A, Luciano M, Davies G, Liewald DC, Harris SE et al. Polygenic risk for schizophrenia is associated with cognitive change between childhood and old age. Biol Psychiatry 2013; 73: 938–943.
Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W et al. Schizophrenia genetic variants are not associated with intelligence. Psychol Med 2013; 73: 525–3.
Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969–976.
Donohoe G, Deary IJ, Glahn DC, Malhotra AK, Burdick KE . Neurocognitive phenomics: examining the genetic basis of cognitive abilities. Psychol Med 2012; 43: 2027–2036.
Dickinson D, Ragland JD, Gold JM, Gur RC . General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiatry 2008; 64: 823–827.
Keefe RS, Harvey PD . Cognitive impairment in schizophrenia. Handb Exp Pharmacol 2012; 213: 11–37.
Keshavan MS, Kulkarni S, Bhojraj T, Francis A, Diwadkar V, Montrose DM, Seidman LJ, Sweeney J . Premorbid cognitive deficits in young relatives of schizophrenia patients. Front Hum Neurosci 2010; 3: 62.
Deary IJ, Penke L, Johnson W . The neuroscience of human intelligence differences. Nat Rev Neurosci 2010; 11: 201–211.
Deary IJ, Johnson W, Houlihan LM . Genetic foundations of human intelligence. Hum Genet 2009; 126: 215–232.
Plomin R . The genetics of g in human and mouse. Nat Rev Neurosci 2001; 2: 136–141.
Glahn DC, Almasy L, Blangero J, Burk GM, Estrada J, Peralta JM et al. Adjudicating neurocognitive endophenotypes for schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 242–249.
Johnson W, Bouchard TJ Jr, Krueger RF, McGue M, Gottesman II . Just one g: Consistent results from three test batteries. Intelligence 2004; 34: 95–107.
Johnson W, Nijenhuis JT, Bouchard TJ.Jr . Still just 1 g: consistent results from five test batteries. Intelligence 2008; 36: 81–95.
Sanders AR, Duan J, Levinson DF, Shi J, He D, Hou C et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry 2008; 165: 497–506.
Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753–757.
Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302–316.
Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry 2011; 69: 472–478.
Guha S, Rees E, Darvasi A, Ivanov D, Ikeda M, Bergen SE et al. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA Psychiatry 2013; 70: 253–260.
Fu J, Festen EA, Wijmenga C . Multi-ethnic studies in complex traits. Hum Mol Genet 2011; 20: R206–R213.
de Candia TR, Lee SH, Yang J, Browning BL, Gejman PV, Levinson DF et al. Additive genetic variation in schizophrenia risk is shared by populations of african and European descent. Am J Hum Genet 2013; 93: 463–470.
N'Diaye A, Chen GK, Palmer CD, Ge B, Tayo B, Mathias RA et al. Identification, replication, and fine-mapping of loci associated with adult height in individuals of african ancestry. PLoS Genet 2011; 7: e1002298.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
Delaneau O, Marchini J, Zagury JF . A linear complexity phasing method for thousands of genomes. Nat Methods 2011; 9: 179–181.
Howie B, Marchini J, Stephens M . Genotype imputation with thousands of genomes. G3 2011; 1: 457–470.
Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR . Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955–959.
Montgomery SB, Lappalainen T, Gutierrez-Arcelus M, Dermitzakis ET . Rare and common regulatory variation in population-scale sequenced human genomes. PLoS Genet 2011; 7: e1002144.
Spearman C . General intelligence objectively determined and measured. Am J Psychology 1904; 15: 201–293.
Jackson JE . A User's Guide to Principal Components. John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2006.
Carroll JB . Human Cognitive Abilities: A Survey of Factor-Analytic Studies. Cambridge University Press: Cambridge, UK, 1993.
Verhaeghen P, Salthouse TA . Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models. Psychol Bull 1997; 122: 231–249.
Yang J, Weedon MN, Purcell S, Lettre G, Estrada K, Willer CJ et al. Genomic inflation factors under polygenic inheritance. Eur J Hum Genet 2011; 19: 807–812.
Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kähler AK, Akterin S et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150–1159.
Yang J, Benyamin B, McEvoy BP, Gordon S, Henders AK, Nyholt DR et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet 2010; 42: 565–569.
Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832–838.
Papaleo F, Lipska BK, Weinberger DR . Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 2012; 62: 1204–1220.
Donohoe G, Walters J, Morris DW, Da Costa A, Rose E, Hargreaves A et al. A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809. Schizophr Res 2011; 125: 304–306.
Krug A, Krach S, Jansen A, Nieratschker V, Witt SH, Shah NJ et al. The effect of neurogranin on neural correlates of episodic memory encoding and retrieval. Schizophr Bull 2013; 39: 141–150.
Ohi K, Hashimoto R, Yasuda Y, Nemoto K, Ohnishi T, Fukumoto M et al. Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia. PLoS ONE 2012; 7: e29780.
Rose EJ, Morris DW, Fahey C, Robertson IH, Greene C, O'Doherty J et al. The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function. Twin Res Hum Genet 2012; 15: 296–303.
Pohlack ST, Nees F, Ruttorf M, Witt SH, Nieratschker V, Rietschel M, Flor H . Risk variant for schizophrenia in the neurogranin gene impacts on hippocampus activation during contextual fear conditioning. Mol Psychiatry 2011; 16: 1072–1073.
Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet 2013; 92: 197–209.
Weedon MN, Lettre G, Freathy RM, Lindgren CM, Voight BF, Perry JR et al. A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet 2007; 39: 1245–1245.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889–894.
Acknowledgements
This work has been supported by grants from the National Institutes of Health (R01 MH079800 and P50 MH080173 to AKM; RC2 MH089964 to TL; R01 MH080912 to DCG; K23 MH077807 to KEB; K01 MH085812 to MCK). Dr Donohoe is generously funded by the Health Research Board (Ireland) and Science Foundation Ireland. Data collection for the TOP cohort was supported by the Research Council of Norway, South-East Norway Health Authority. The NCNG study was supported by Research Council of Norway Grants 154313/V50 and 177458/V50. The NCNG GWAS was financed by grants from the Bergen Research Foundation, the University of Bergen, the Research Council of Norway (FUGE, Psykisk Helse), Helse Vest RHF and Dr Einar Martens Fund. The Helsinki Birth Cohort Study has been supported by grants from the Academy of Finland, the Finnish Diabetes Research Society, Folkhälsan Research Foundation, Novo Nordisk Foundation, Finska Läkaresällskapet, Signe and Ane Gyllenberg Foundation, University of Helsinki, Ministry of Education, Ahokas Foundation, Emil Aaltonen Foundation. For the LBC cohort, phenotype collection was supported by Research Into Ageing (continues as part of Age UK The Disconnected Mind project). Genotyping was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC), and MRC is gratefully acknowledged. We are grateful to investigators, led by Pablo Gejman, who have made data for the MGS cohort publicly available through dbGAP (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000167.v1.p1;/cgi-bin/study.cgi?study_id=phs000021.v2.p1).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lencz, T., Knowles, E., Davies, G. et al. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry 19, 168–174 (2014). https://doi.org/10.1038/mp.2013.166
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2013.166
Keywords
This article is cited by
-
Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia
Schizophrenia (2023)
-
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
Molecular Psychiatry (2023)
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology (2023)
-
Clustering of cognitive subtypes in schizophrenia patients and their siblings: relationship with regional brain volumes
Schizophrenia (2022)
-
Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology
Nature Communications (2022)